Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

MAP 2018 - Banner


UNICANCER (www.unicancer.fr) unites all of the French Cancer Centres (FCCCs): these private non-profit health institutions are exclusively devoted to healthcare, research, and education and training in oncology.

The leading edge in oncology in France, and key players internationally, Cancer Centres participate in public hospital service and provide care for the patient in accordance with conventional tariffs, without any overrunning of fees.

Research represents one of the fundamental missions of the FCCCs. It enables patients to benefit from diagnostic and therapeutic innovations by calling on all of the disciplines involved in cancer care. In each Centre, multidisciplinary teams associate care and research units in order to develop integrated research on cancer, based on the clinical, fundamental and translational research continuum.

Unicancer is an academic promoter. Its clinical research department, as an oncology clinical research operator, works directly with the research units of the Cancer Centres and (the) other health institutions (university hospital centres, hospital centres, clinics, etc.) in France and abroad.


Cancer Research UK (CRUK) is the largest independent funder of cancer research in Europe, and the world’s leading charity dedicated to cancer research.

Our vision is to bring forward the day when all cancers are cured. We invest around €450m in world-leading research across all cancer types. We fund high-calibre, innovative research that we believe has the potential to provide the greatest benefit to the public and cancer patients.

Our diverse portfolio spans a breadth of research areas, from fundamental discovery research to understand the biology and causes of cancer, through translational research to bring the latest discoveries to the benefit of patients, to drug discovery to identify potential new treatments, clinical research to deliver the best treatments for patients, and population-level research covering epidemiology, prevention and early detection of cancer.

We are proud to support 4,000 researchers, doctors and nurses in institutions across the UK and internationally. Our progress is dependent on these outstanding individuals and teams conducting high-quality research.

We support over 250 clinical trials, with more than 22,000 people joining our trials each year.

We work in partnership to achieve the greatest impact. We are the gateway through which researchers and institutions can join forces with academic collaborators and commercial partners. Our open, collaborative research community expands the bounds of what research teams can achieve individually, and our established industry links and proven commercialisation experience enable us to develop new ideas to their full potential.

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings
  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.